K. Konopa

发表

Outcomes According to ALK Status Determined by Central Immunohistochemistry or Fluorescence In Situ Hybridization in Patients With ALK-Positive NSCLC Enrolled in the Phase 3 ALEX Study.

A. Shaw, S. Ou, T. Mok, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer

F. Hirsch, R. Dziadziuszko, J. Jassem, 2012, Journal of Thoracic Oncology.

(CA)n microsatellite polymorphism of ERBB-1 in breast cancer.

J. Jassem, B. Brandt, J. Jaśkiewicz, 2006, European journal of cancer.

Thymidylate Synthase Protein Expression by IHC and Gene Copy Number by SISH Correlate and Show Great Variability in Non–Small Cell Lung Cancer

F. Hirsch, R. Dziadziuszko, J. Jassem, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer.

N. Pavlakis, S. Novello, S. Peters, 2019, Lung cancer.

[Small-cell lung cancer diagnostic and therapeutic recommendations of Polish Lung Cancer Group].

K. Roszkowski, W. Olszewski, R. Ramlau, 2007, Pneumonologia i alergologia polska.

Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial

V. Remouchamps, C. Faivre-Finn, F. Blackhall, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.

V. Remouchamps, C. Faivre-Finn, F. Blackhall, 2017 .

Prisoners' attitudes towards cigarette smoking and smoking cessation: a questionnaire study in Poland

E. Jassem, A. Siemińska, K. Konopa, 2006, BMC public health.

Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?

K. Konopa, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non–small Cell Lung Cancer in the Global Phase III ALEX Trial

A. Shaw, S. Ou, T. Mok, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

The role of pemetrexed combined with targeted agents for non-small cell lung cancer.

J. Jassem, K. Konopa, 2010, Current drug targets.

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number

R. Dziadziuszko, J. Jassem, A. Szczesna, 2016, Oncotarget.

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)

C. Paweletz, P. Angenendt, H. Wakelee, 2016, Clinical Cancer Research.

Targeted therapies in advanced non-small cell lung cancer: success or failure?

J. Jassem, K. Konopa, E. Szutowicz, 2011 .

Abnormalities of erbB oncogene family in breast cancer

J. Jassem, J. Jaśkiewicz, S. Treści, 2004 .

Contralateral esophageal sparing technique in definitive radiotherapy for non-small cell lung cancer: dosimetric parameters and normal tissue complication probability modeling

R. Dziadziuszko, J. Jassem, J. Kamińska, 2022, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance.

R. Dziadziuszko, J. Jassem, T. Soussi, 2001, Lung cancer.

Outcomes According to ALK Status Determined by Central IHC or FISH in Patients with ALK-Positive NSCLC Enrolled in the Phase III ALEX Study.

A. Shaw, S. Peters, D. Camidge, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

p53 codon 72 polymorphism in cervical cancer patients and healthy women from Poland.

A. Podhajska, A Dybikowska, A Dettlaff, 2000, Acta biochimica Polonica.

The prevalence of cigarette smoking among school pupils staying at summer camps.

J. Słomiński, A. Siemińska, K. Konopa, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The feasibility study on continuous 7-day-a-week external beam irradiation in locally advanced cervical cancer: a report on acute toxicity.

J. Jassem, K. Serkies, T. Sawicki, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.